Mixed mouse cSCCs treated with anti-PD-L1 antibody showed a reduction in tumor growth, accompanied by a significant increase in the percentage of active CD8+ and NK cells (Fig. 6a–e, k-o and Supplementary Fig. 7a, c–f, k–o). The gene discussed is CD8A; the disease is neoplasm.